Coronavirus vaccine

With cases soaring, Malaysia hopes to quicken the pace of vaccinations and head off further deaths from the virus.

For myriad reasons, vaccination programs in Central Asia are proceeding slowly. Hesitancy is one factor.

Indonesia aims to inoculate more than 181 million of its 270 million people by March 2022.

Canberra now has a plan to begin vaccinations, but hesitancy has been on the rise among Australians.

Indonesia's vaccination program is the first large-scale use outside of China of the Sinovac Biotech Ltd. vaccine. 

The emergence of a much more contagious variant of COVID-19 comes as Australia rolls out vaccines. 

Uzbekistan launches trials of a Chinese vaccine, but purchases Russian vaccine.

Australia is well-positioned to help roll-out a COVID-19 vaccine across the Pacific and Southeast Asia; India’s vaccine manufacturing capability would be a huge boost to that effort.

Solar-powered vaccine logistics may present an important opportunity for the ISA amid the global pandemic.